Stay updated with breaking news from Contract Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Teva and mAbxience enter into a strategic global partnership for in-licensing of an oncology biosimilar candidate Agreement signals a major step in mAbxience's global expansion strategy and...
CRANBURY, N.J. & DUBLIN, April 03, 2024--Experic appoints Philip Dunne as Director of EU Operations, bringing 25+ years of clinical trial supply expertise to their new Dublin facility.
Asit C Mehta is bullish on Piramal Pharma has recommended buy rating on the stock with a target price of Rs 171 in its research report dated April 01 2024.
The biopharmaceutical landscape is flourishing, with antibody-based therapeutics at the forefront of innovation. Click to read more...
MADISON, Wis.--(BUSINESS WIRE)--Apr 2, 2024--